Clear information about TMS
We answer common questions about safety, indications, outcomes, and clinical assessment so you can make informed decisions.
For most patients, TMS is painless. Mild local discomfort at the stimulation site may occur and is usually transient.
No. It is a non-invasive outpatient therapy. It is performed without anesthesia and patients usually return to regular activities after each session.
Most patients report no adverse effects. Some may experience mild dizziness, transient fatigue, local discomfort, or neck pain from session posture.
Serious effects are very rare. Seizures have been reported in less than 1% of cases, which is why specialized evaluation and clinical follow-up are essential.
Treatment-resistant depression, depression with comorbid anxiety, OCD, substance-use support including smoking cessation, and selected migraine protocols.
Yes, as research-stage applications with promising results. In these cases, TMS is indicated individually and always as a complement to conventional treatment.
Many patients report lower chronic pain, better mood and anxiety symptoms, improved sleep, greater function, and better quality of life. Response varies per case.
Because every brain, diagnosis, and clinical history is different. At Fibroclinic, Dr. Kathy Fowler's evaluation defines whether TMS is suitable and how to personalize the protocol safely.